216 related articles for article (PubMed ID: 32949960)
21. DprE1 Is a Vulnerable Tuberculosis Drug Target Due to Its Cell Wall Localization.
Brecik M; Centárová I; Mukherjee R; Kolly GS; Huszár S; Bobovská A; Kilacsková E; Mokošová V; Svetlíková Z; Šarkan M; Neres J; Korduláková J; Cole ST; Mikušová K
ACS Chem Biol; 2015 Jul; 10(7):1631-6. PubMed ID: 25906160
[TBL] [Abstract][Full Text] [Related]
22. The Veterinary Anti-Parasitic Selamectin Is a Novel Inhibitor of the
Ezquerra-Aznárez JM; Degiacomi G; Gašparovič H; Stelitano G; Sammartino JC; Korduláková J; Governa P; Manetti F; Pasca MR; Chiarelli LR; Ramón-García S
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054958
[TBL] [Abstract][Full Text] [Related]
23. A Rational Approach To Antitubercular Drug Design: Molecular Docking, Prediction of ADME Properties and Evaluation of Antitubercular Activity of Novel Isonicotinamide Scaffold.
Das P; Gumma SR; Nayak A; Menghani S; Mandhadi JR; Prabhu PP
Recent Adv Antiinfect Drug Discov; 2024; 19(2):148-158. PubMed ID: 37723955
[TBL] [Abstract][Full Text] [Related]
24. Decaprenylphosphoryl-β-D-ribose 2'-epimerase from Mycobacterium tuberculosis is a magic drug target.
Manina G; Pasca MR; Buroni S; De Rossi E; Riccardi G
Curr Med Chem; 2010; 17(27):3099-108. PubMed ID: 20629622
[TBL] [Abstract][Full Text] [Related]
25. Structure-Based Drug Design and Characterization of Sulfonyl-Piperazine Benzothiazinone Inhibitors of DprE1 from Mycobacterium tuberculosis.
Piton J; Vocat A; Lupien A; Foo CS; Riabova O; Makarov V; Cole ST
Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30012754
[TBL] [Abstract][Full Text] [Related]
26. Discovery of
Yang L; Hu X; Lu Y; Xu R; Xu Y; Ma W; Alam MS; Zhang T; Chai X; Lei Y; Ye Q; Dong X; Kang Y; Che J; Hou T; Li D
J Med Chem; 2024 Feb; 67(3):1914-1931. PubMed ID: 38232131
[TBL] [Abstract][Full Text] [Related]
27. Current Affairs, Future Perspectives of Tuberculosis and Antitubercular Agents.
Gawad J; Bonde C
Indian J Tuberc; 2018 Jan; 65(1):15-22. PubMed ID: 29332642
[TBL] [Abstract][Full Text] [Related]
28. Chemical Space Exploration of DprE1 Inhibitors Using Chemoinformatics and Artificial Intelligence.
Chhabra S; Kumar S; Parkesh R
ACS Omega; 2021 Jun; 6(22):14430-14441. PubMed ID: 34124465
[TBL] [Abstract][Full Text] [Related]
29. Decaprenyl-phosphoryl-ribose 2'-epimerase (DprE1): challenging target for antitubercular drug discovery.
Gawad J; Bonde C
Chem Cent J; 2018 Jun; 12(1):72. PubMed ID: 29936616
[TBL] [Abstract][Full Text] [Related]
30. Exploring biogenic chalcones as DprE1 inhibitors for antitubercular activity via in silico approach.
Rathod S; Chavan P; Mahuli D; Rochlani S; Shinde S; Pawar S; Choudhari P; Dhavale R; Mudalkar P; Tamboli F
J Mol Model; 2023 Mar; 29(4):113. PubMed ID: 36971900
[TBL] [Abstract][Full Text] [Related]
31. An integrated computational approach of molecular dynamics simulations, receptor binding studies and pharmacophore mapping analysis in search of potent inhibitors against tuberculosis.
Agarwal S; Verma E; Kumar V; Lall N; Sau S; Iyer AK; Kashaw SK
J Mol Graph Model; 2018 Aug; 83():17-32. PubMed ID: 29753941
[TBL] [Abstract][Full Text] [Related]
32. Structural and inhibition analysis of novel sulfur-rich 2-mercaptobenzothiazole and 1,2,3-triazole ligands against Mycobacterium tuberculosis DprE1 enzyme.
Karan S; Kashyap VK; Shafi S; Saxena AK
J Mol Model; 2017 Aug; 23(8):241. PubMed ID: 28744747
[TBL] [Abstract][Full Text] [Related]
33. Identification of a pyrimidinetrione derivative as the potent DprE1 inhibitor by structure-based virtual ligand screening.
Gao Y; Xie J; Tang R; Yang K; Zhang Y; Chen L; Li H
Bioorg Chem; 2019 Apr; 85():168-178. PubMed ID: 30616098
[TBL] [Abstract][Full Text] [Related]
34. 2,6-Disubstituted 7-(naphthalen-2-ylmethyl)-7H-purines as a new class of potent antitubercular agents inhibiting DprE1.
Finger V; Kucera T; Kafkova R; Muckova L; Dolezal R; Kubes J; Novak M; Prchal L; Lakatos L; Andrs M; Hympanova M; Marek J; Kufa M; Spiwok V; Soukup O; Mezeiova E; Janousek J; Nevosadova L; Benkova M; Kitson RRA; Kratky M; Bősze S; Mikusova K; Hartkoorn R; Roh J; Korabecny J
Eur J Med Chem; 2023 Oct; 258():115611. PubMed ID: 37421887
[TBL] [Abstract][Full Text] [Related]
35. Discovery of novel reversible inhibitor of DprE1 based on benzomorpholine for the treatment of tuberculosis.
Xiang W; He H; Duan X; He Z; Xu X; Liao M; Teng F; Li X; Luo T; Zeng J; Yu L; Gao C
Microbiol Spectr; 2023 Sep; 11(5):e0472122. PubMed ID: 37698416
[TBL] [Abstract][Full Text] [Related]
36. Design, synthesis and evaluation of covalent inhibitors of DprE1 as antitubercular agents.
Liu L; Kong C; Fumagalli M; Savková K; Xu Y; Huszár S; Sammartino JC; Fan D; Chiarelli LR; Mikušová K; Sun Z; Qiao C
Eur J Med Chem; 2020 Dec; 208():112773. PubMed ID: 32898793
[TBL] [Abstract][Full Text] [Related]
37. Discovery of pyrazolopyridones as a novel class of noncovalent DprE1 inhibitor with potent anti-mycobacterial activity.
Panda M; Ramachandran S; Ramachandran V; Shirude PS; Humnabadkar V; Nagalapur K; Sharma S; Kaur P; Guptha S; Narayan A; Mahadevaswamy J; Ambady A; Hegde N; Rudrapatna SS; Hosagrahara VP; Sambandamurthy VK; Raichurkar A
J Med Chem; 2014 Jun; 57(11):4761-71. PubMed ID: 24818517
[TBL] [Abstract][Full Text] [Related]
38. GtrA Protein Rv3789 Is Required for Arabinosylation of Arabinogalactan in Mycobacterium tuberculosis.
Kolly GS; Mukherjee R; Kilacsková E; Abriata LA; Raccaud M; Blaško J; Sala C; Dal Peraro M; Mikušová K; Cole ST
J Bacteriol; 2015 Dec; 197(23):3686-97. PubMed ID: 26369580
[TBL] [Abstract][Full Text] [Related]
39. Discovery of Novel Thiophene-arylamide Derivatives as DprE1 Inhibitors with Potent Antimycobacterial Activities.
Wang P; Batt SM; Wang B; Fu L; Qin R; Lu Y; Li G; Besra GS; Huang H
J Med Chem; 2021 May; 64(9):6241-6261. PubMed ID: 33852302
[TBL] [Abstract][Full Text] [Related]
40. Optimization of Hydantoins as Potent Antimycobacterial Decaprenylphosphoryl-β-d-Ribose Oxidase (DprE1) Inhibitors.
Balabon O; Pitta E; Rogacki MK; Meiler E; Casanueva R; Guijarro L; Huss S; Lopez-Roman EM; Santos-Villarejo Á; Augustyns K; Ballell L; Aguirre DB; Bates RH; Cunningham F; Cacho M; Van der Veken P
J Med Chem; 2020 May; 63(10):5367-5386. PubMed ID: 32342688
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
